Other OTC Pharmaceuticals (Pharmacies) - Sudan

  • Sudan
  • Revenue in the Other OTC Pharmaceuticals market is projected to reach US$8.61m in 2024.
  • Revenue is expected to show an annual growth rate (CAGR 2024-2029) of 4.68%, resulting in a market volume of US$10.82m by 2029.
  • In global comparison, most revenue will be generated in the United States (US$4,981.00m in 2024).
  • In relation to total population figures, per person revenues of US$0.17 are generated in 2024.

Key regions: France, Australia, India, South Korea, Germany

 
Market
 
Region
 
Region comparison
 
Currency
 

Analyst Opinion

The Other OTC Pharmaceuticals (Pharmacies) market in Sudan is experiencing significant growth and development.

Customer preferences:
Customers in Sudan have shown a growing demand for over-the-counter (OTC) pharmaceutical products. This can be attributed to several factors, including the increasing awareness of self-medication, convenience, and affordability. Sudanese consumers are becoming more proactive in managing their own health and are seeking accessible and affordable healthcare options. As a result, they are turning to OTC pharmaceuticals available in local pharmacies to treat common ailments and minor health issues.

Trends in the market:
One of the key trends in the Other OTC Pharmaceuticals (Pharmacies) market in Sudan is the rising popularity of herbal and traditional remedies. Sudan has a rich history of traditional medicine, and many consumers are embracing these natural remedies for various health conditions. This trend is driven by the perception that herbal medicines are safer and have fewer side effects compared to synthetic drugs. As a result, local pharmacies are expanding their product offerings to include a wide range of herbal and traditional OTC pharmaceuticals to cater to this growing demand. Another trend in the market is the increasing availability of generic OTC pharmaceuticals. Generic drugs are more affordable compared to their branded counterparts, making them a preferred choice for price-sensitive consumers in Sudan. Local pharmacies are stocking a larger variety of generic OTC pharmaceuticals to cater to this demand. This trend is also supported by the government's efforts to promote the use of generic drugs as a cost-effective solution for healthcare.

Local special circumstances:
Sudan is a country with a large rural population and limited access to healthcare facilities. This has led to an increased reliance on local pharmacies for basic healthcare needs. Pharmacies in Sudan often serve as the first point of contact for individuals seeking medical advice and treatment. As a result, they play a crucial role in providing essential healthcare services to the population, including the provision of OTC pharmaceuticals.

Underlying macroeconomic factors:
Sudan has been experiencing economic challenges in recent years, including high inflation and currency depreciation. These factors have had an impact on the Other OTC Pharmaceuticals (Pharmacies) market. The rising cost of healthcare services and prescription medications has made OTC pharmaceuticals a more affordable option for many Sudanese consumers. Additionally, the depreciation of the local currency has made imported pharmaceutical products more expensive, leading to an increased demand for locally-produced OTC medications. Furthermore, the ongoing COVID-19 pandemic has also influenced the market dynamics. The pandemic has created a heightened awareness of health and hygiene among the population, leading to increased demand for OTC pharmaceuticals such as hand sanitizers, disinfectants, and immune-boosting supplements. Pharmacies in Sudan have responded to this demand by stocking a wider range of these products to meet the needs of the consumers. In conclusion, the Other OTC Pharmaceuticals (Pharmacies) market in Sudan is witnessing growth and development driven by customer preferences for accessible and affordable healthcare options. The increasing demand for herbal and traditional remedies, the availability of generic OTC pharmaceuticals, and the reliance on pharmacies for basic healthcare needs are key trends in the market. Special circumstances such as limited access to healthcare facilities and the role of pharmacies as the first point of contact for medical advice contribute to the market's development. Underlying macroeconomic factors, including economic challenges and the impact of the COVID-19 pandemic, also influence the market dynamics in Sudan.

Methodology

Data coverage:

The data encompasses B2C enterprises. Figures are based on offline and online spending by consumers, including VAT. Not included are B2B and B2G sales, or other pharmaceutical sales through hospitals or retail stores such as supermarkets.

Modeling approach:

Market sizes are determined through a bottom-up approach, building on specific predefined factors for each market market. As a basis for evaluating markets, we use industry associations, third-party studies and reports and survey results from our primary research (e.g., the Statista Global Consumer Survey). In addition, we use relevant key market indicators and data from country-specific associations, such as healthcare expenditure per country, consumer healthcare spending, GDP and internet penetration. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the relevant market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods. For forecasting digital trends such as the online-pharmacy sales share we use exponential trend smoothing and the s-curve method. The main drivers are healthcare expenditure per country and consumer healthcare spending.

Additional notes:

The data is modeled using current exchange rates. The impact of the COVID-19 pandemic and the Russia-Ukraine war are considered at a country-specific level. The market is updated twice a year. GCS data is reweighted for representativeness.

Overview

  • Revenue
  • Analyst Opinion
  • Global Comparison
  • Methodology
Please wait

Contact

Get in touch with us. We are happy to help.
Statista Locations
Contact Meredith Alda
Meredith Alda
Sales Manager– Contact (United States)

Mon - Fri, 9am - 6pm (EST)

Contact Yolanda Mega
Yolanda Mega
Operations Manager– Contact (Asia)

Mon - Fri, 9am - 5pm (SGT)

Contact Kisara Mizuno
Kisara Mizuno
Senior Business Development Manager– Contact (Asia)

Mon - Fri, 10:00am - 6:00pm (JST)

Contact Lodovica Biagi
Lodovica Biagi
Director of Operations– Contact (Europe)

Mon - Fri, 9:30am - 5pm (GMT)

Contact Carolina Dulin
Carolina Dulin
Group Director - LATAM– Contact (Latin America)

Mon - Fri, 9am - 6pm (EST)